Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,033B 10.84B 9.68B 9.02B 8.18B 15.41B 15.53B 108B 42.31B 535B 40.7B 39.8B 1,717B P/E 2027 *
28x
P/E 2028 * 21.5x
Enterprise Value 1,001B 10.5B 9.38B 8.74B 7.93B 14.94B 15.05B 105B 41B 518B 39.44B 38.57B 1,664B EV / Sales 2027 *
2.84x
EV / Sales 2028 * 2.5x
Free-Float
69.69%
Yield 2027 *
0.61%
Yield 2028 * 0.68%
1 day+0.74%
1 week+2.62%
Current month+0.30%
1 month+6.77%
3 months-0.47%
6 months+0.62%
Current year-2.47%
1 week 1,166.75
Extreme 1166.75
1,250.95
1 month 1,134
Extreme 1134
1,252
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 A Other

Global Head of Quality and PV

35,600 0.0043% -
12/18/25 A Other

Chairman

85,738,125 10.2732%
12/18/25 A Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%+2.62%-1.99%+12.09% 10.72B
-1.36%+2.05%+39.95%+91.07% 1,054B
-5.73%-1.71%+30.35%+59.03% 636B
-2.40%+3.24%+19.03%+85.00% 497B
-2.39%+1.75%+65.11%+37.06% 359B
-0.06%+3.12%+23.98%+42.38% 345B
-0.55%+2.42%+13.66%+33.97% 273B
-1.08%+1.12%-6.93%+6.98% 246B
-1.13%+2.45%+42.29%+44.84% 226B
-1.67%+2.27%+26.23%+92.70% 187B
Average -0.80%+3.01%+25.17%+50.51% 383.29B
Weighted average by Cap. -0.68%+3.19%+31.03%+63.19%

Financials

2027 *2028 *
Net sales 352B 3.69B 3.3B 3.07B 2.79B 5.25B 5.29B 36.76B 14.42B 182B 13.87B 13.57B 585B 393B 4.13B 3.68B 3.43B 3.11B 5.87B 5.91B 41.06B 16.11B 204B 15.49B 15.15B 654B
Net income 36.53B 383M 342M 319M 289M 545M 549M 3.82B 1.5B 18.93B 1.44B 1.41B 60.73B 48.57B 510M 455M 424M 385M 725M 730M 5.07B 1.99B 25.16B 1.91B 1.87B 80.74B
Net Debt -31.96B -335M -299M -279M -253M -477M -481M -3.34B -1.31B -16.56B -1.26B -1.23B -53.13B -51.37B -539M -481M -449M -407M -767M -772M -5.36B -2.1B -26.61B -2.02B -1.98B -85.39B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
13/10/26 ₹1,239.65 +0.74% 125,767
12/10/26 ₹1,230.50 +2.96% 110,740
09/10/26 ₹1,195.10 +1.28% 82,380
08/10/26 ₹1,180.00 -1.86% 126,097
07/10/26 ₹1,202.40 -0.56% 69,824
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,239.65INR
Average target price
1,283.65INR
Spread / Average Target
+3.55%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Dr. Reddy's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock